SNMMI and ASNC issue joint guidelines for quantification of myocardial blood flow using PET

February 13, 2018, Society of Nuclear Medicine and Molecular Imaging
In this example, from an 81-year-old man with hypertension and dyslipidemia, relative MPI (A) with 82Rb PET demonstrated only mild, reversible perfusion abnormality involving distribution of left anterior descending coronary artery. However, MFR was severely reduced globally at 1.11. Nearly entire heart had severely reduced MFR except for inferior and inferolateral walls, where it was only moderately reduced. Coronary angiography (B) showed severe stenosis of mid portion of left main coronary artery. Credit: American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) Cardiovascular Council and the American Society of Nuclear Cardiology (ASNC) have issued the joint position paper, Clinical Quantification of Myocardial Blood Flow Using PET, which was jointly published in the Journal of Nuclear Cardiology and The Journal of Nuclear Medicine.

Radionuclide (MPI) is among the most commonly performed diagnostic tests in cardiology. Positron emission tomography (PET) can quantify global and regional myocardial , assess regional perfusion abnormalities with relative MPI, and assess function abnormalities and chamber dimensions. Quantification of myocardial blood flow requires accurate measurement of the total tracer activity transported by the arterial blood and delivered to the myocardium over time.

This position statement consolidates and updates technical considerations for clinical quantification of myocardial blood flow and myocardial flow reserve, and it summarizes and updates the scientific basis for their clinical application.

"Quantification of myocardial blood flow is the next great leap in nuclear , and this document summarizes the data supporting its use and offers guidance to those who are planning to make these measurements in practice," explains Venkatesh L. Murthy, MD, PhD, vice president-elect of SNMMI's Cardiovascular Council and a lead author of the position statement.

Prem Soman, MD, PhD, FACC, FASNC, president of ASNC and co-author of the document, points out, "This is a comprehensive document which offers many useful insights into the theory and practice of PET myocardial perfusion imaging."

The position paper states, "Quantification of myocardial blood flow and myocardial flow reserve represents a substantial advance for diagnostic and prognostic evaluation of suspected or established coronary artery disease. These methods are at the cusp of translation to clinical practice." It notes, however, that further efforts are necessary to standardize measures across laboratories, radiotracers, equipment, and software—pointing out, "Most critically, data are needed supporting improved clinical outcomes when treatment selection is based on these measures."

Explore further: SNMMI publishes appropriate use criteria for somatostatin receptor PET imaging

More information: Venkatesh L. Murthy et al, Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC, Journal of Nuclear Medicine (2017). DOI: 10.2967/jnumed.117.201368

Related Stories

SNMMI publishes appropriate use criteria for somatostatin receptor PET imaging

January 4, 2018
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors. This AUC is part of a new series developed by SNMMI ...

Pioglitazone improves left ventricular diastolic function

September 29, 2017
(HealthDay)—Pioglitazone improves whole-body and myocardial insulin sensitivity, left ventricular (LV) diastolic function, and systolic function in patients with type 2 diabetes, according to a small study published online ...

Molecular imaging 'sees' inside coronary arteries to measure disease

June 11, 2012
Patients with cardiovascular disease will now benefit from a powerful new molecular imaging tool to detect disease in the main arteries supplying oxygen to the heart, say researchers presenting studies at the Society of Nuclear ...

Halving the radiation dose in cardiac perfusion imaging is now 'feasible'

May 17, 2011
A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.

Exercise perfusion CT imaging IDs coronary stenosis

March 11, 2015
(HealthDay)—For patients suspected of having hemodynamically significant coronary stenosis, exercise computed tomography (CT) myocardial perfusion imaging is feasible and accurate, according to a study published in the ...

Head-to-head comparison of non-invasive coronary artery imaging

August 29, 2016
For patients presenting for the first time with suspected coronary artery disease (CAD) clinicians have had a number of non-invasive diagnostic tests to choose from, but little evidence for which is best.

Recommended for you

Eating yogurt may reduce cardiovascular disease risk

February 15, 2018
A new study in the American Journal of Hypertension, published by Oxford University Press, suggests that higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women.

Newly discovered gene may protect against heart disease

February 14, 2018
Scientists have identified a gene that may play a protective role in preventing heart disease. Their research revealed that the gene, called MeXis, acts within key cells inside clogged arteries to help remove excess cholesterol ...

Blood thinners may raise stroke risk in over-65s with kidney disease

February 14, 2018
People over 65 years old may be increasing their stroke risk by taking anticoagulants for an irregular heartbeat if they also have chronic kidney disease, finds a new study led by UCL, St George's, University of London and ...

Cardiac macrophages found to contribute to a currently untreatable type of heart failure

February 14, 2018
A team of Massachusetts General Hospital (MGH) investigators has discovered, for the first time, that the immune cells called macrophages contribute to a type of heart failure for which there currently is no effective treatment. ...

Study maps molecular mechanisms crucial for new approach to heart disease therapy

February 13, 2018
Creating new healthy heart muscle cells within a patient's own ailing heart. This is how scientists hope to reverse heart disease one day. Today, a new study led by UNC-Chapel Hill researchers reveals key molecular details ...

Quality toolkit improves care in Indian hospitals

February 13, 2018
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.